###begin article-title 0
Exendin-4 Stimulation of Cyclin A2 in beta-Cell Proliferation
###end article-title 0
###begin p 1
###xml 42 59 42 59 <email xmlns:xlink="http://www.w3.org/1999/xlink">mhussai4@jhmi.edu</email>
Corresponding author: Mehboob A. Hussain, mhussai4@jhmi.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-beta-Cell proliferation is an important mechanism underlying beta-cell mass adaptation to metabolic demands. We have examined effects, in particular those mediated through intracellular cAMP signaling, of the incretin hormone analog exendin-4 on cell cycle regulation in beta-cells.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
###xml 363 368 <span type="species:ncbi:10090">mouse</span>
RESEARCH DESIGN AND METHODS-Changes in islet protein levels of cyclins and of two critical cell cycle regulators cyclin kinase inhibitor p27 and S-phase kinase-associated protein 2 (Skp2) were assessed in mice treated with exendin-4 and in a mouse model with specific upregulation of nuclear cAMP signaling exhibiting increased beta-cell proliferation (CBP-S436A mouse). Because cyclin A2 was stimulated by cAMP, we assessed the role of cylcin A2 in cell cycle progression in Min6 and isolated islet beta-cells.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
RESULTS-Mice treated with exendin-4 showed increased beta-cell proliferation, elevated islet protein levels of cyclin A2 with unchanged D-type cyclins, elevated PDX-1 and Skp2 levels, and reduced p27 levels. Exendin-4 stimulated cyclin A2 promoter activity via the cAMP-cAMP response element binding protein pathway. CBP-S436A islets exhibited elevated cyclin A2, reduced p27, and no changes in D-type cyclins, PDX-1, or Skp2. In cultured islets, exendin-4 increased cyclin A2 and Skp2 and reduced p27. Cyclin A2 overexpression in primary islets increased proliferation and reduced p27. In Min6 cells, cyclin A2 knockdown prevented exendin-4-stimulated proliferation. PDX-1 knockdown reduced exendin-4-stimulated cAMP synthesis and cyclin A2 transcription.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-Cyclin A2 is required for beta-cell proliferation, exendin-4 stimulates cyclin A2 expression via the cAMP pathway, and exendin-4 stimulation of cAMP requires PDX-1.
###end p 6
###begin p 7
Published ahead of print at  on 10 June 2008.
###end p 7
###begin p 8
W.-J.S. and W.E.S. contributed equally to this work.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 352 353 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 439 440 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 441 442 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
Pancreatic beta-cell mass is dynamic and responds to variations in metabolic demand on insulin production. The inability of the endocrine pancreas to adapt to changing insulin demand (inadequate beta-cell mass) is found both in type 1 and type 2 diabetes. Increasing beta-cell mass by regeneration may ameliorate or correct both type 1 and 2 diabetes (1). Within the pancreas, beta-cells regenerate predominantly by beta-cell replication (2,3). In this context, insight into the mechanisms underlying beta-cell proliferation and cell cycle regulation, may provide potential targets for therapy in situations of inadequate beta-cell mass.
###end p 10
###begin p 11
###xml 154 155 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 299 300 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 375 376 369 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 535 536 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 542 543 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 631 632 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 782 783 776 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 909 910 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 911 912 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1141 1142 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1143 1144 1125 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 1306 1307 1282 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 1587 1588 1557 1558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
The incretin hormone glucagon-like peptide-1 (GLP-1) and its long-acting peptide analog exendin-4 stimulate beta-cell proliferation in vitro and in vivo (4), leading to increased beta-cell mass in rodents and amelioration of glucose metabolism in diabetic animal models and human diabetic subjects (4). Downstream effectors of the GLP-1 signaling to the cell nucleus include 1) the epidermal growth factor receptor-phosphoinositol 3-kinase (PI 3-kinase)-protein kinase B (PKB/Akt)-forkhead box transcription factor O1 (FoxO1) pathway (5) and 2) the cAMP-protein kinase A (PKA)-cAMP response element binding protein (CREB) pathway (4). Activation of the PI 3-kinase pathway results in phosphorylation and nuclear exclusion of FoxO1, thereby derepressing PDX-1 transcription (rev. in 6). Insulin and insulin-like growth factor stimulation of beta-cell proliferation converge on the PKB/Akt-FoxO1-PDX-1 pathway (6,7). Transgenic beta-cell-specific overexpression of phosphorylation-defective, nuclear FoxO1 results in reduced nuclear PDX-1, reduced beta-cell number and islet size, and diminished beta-cell proliferation response to exendin-4 (5,6). In addition, beta-cell-specific deletion of PDX-1 in adult mice results in reduced response to GLP-1 effects on beta-cell insulin secretion and proliferation (8), indicating that incretin hormone effects on beta-cell proliferation require adequate PDX-1 levels. In contrast to the PI 3-kinase-mediated pathway, little is known on the specific effects of exendin-4 on cell cycle regulation in beta-cells via the cAMP-CREB-signaling pathway (9).
###end p 11
###begin p 12
###xml 280 281 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 465 466 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 652 653 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 654 656 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 714 716 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 1434 1440 <span type="species:ncbi:10090">murine</span>
We have interrogated exendin-4 and cAMP-CREB-mediated effects on cell cycle regulation in beta-cells, taking advantage of the restricted expression of exendin-4 receptors, which-apart from some areas in the central nervous system-are found predominantly on pancreatic beta-cells (4). In addition, we have used a mouse model with specific nuclear upregulation of cAMP-CREB-CREB binding protein (CBP) action and enhanced in vivo and in vitro beta-cell proliferation (9) to specifically assess the role of cAMP-CREB-regulated transcription on cell cycle regulation. For exendin-4 effects on the cell cycle regulatory proteins, we have focused on cyclins (3,10) and S-phase kinase-associated protein 2 (Skp2) and p27 (11), which are critical regulators of cell cycle control in beta-cells. In contrast to current understanding that only D-type cyclins respond to extracellular growth factors, we were surprised to find that in beta-cells, cyclin A2 expression is upregulated by exendin-4 directly by cAMP-PKA-CREB-CBP signaling. Our in vivo studies indicate that upon exendin-4 stimulation of beta-cells, cyclin A2 protein levels increase, whereas D-type cyclin levels do not change. In addition, exendin-4 treatment is accompanied by decreased p27 and concomitant increase in Skp2 protein, which in cultured Min6 cells is stimulated by a PI 3-kinase-dependent pathway. Upregulation of cyclin A2 levels by lentiviral infection of primary murine beta-cells is sufficient to increase proliferation activity. Furthermore, our studies suggest that in beta-cells, homeodomain transcription factor PDX-1 expression is necessary for generating cAMP, which is required for exendin-4 effects on cyclin A2 expression via PKA-CREB-CBP.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin p 14
###xml 248 250 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 256 258 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
Animal studies were approved in advance by the institutional animal care and use committee of Johns Hopkins University. All animal studies were conducted with mice approximately2-3 months of age. C57Bl/6J were treated with exendin-4 in 10 nmol . kg-1 . day-1 i.p. PBS for 5 days or PBS only before islet isolation or tissue extraction. For beta-cell apoptosis induction, 6-h-fasted mice were treated with 250 mg/kg streptozotocin (STZ; Sigma-Aldrich) in citrate buffer (pH 3) i.p. 24 h before pancreas harvest.
###end p 14
###begin p 15
###xml 93 94 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 95 97 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 516 517 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 518 520 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 658 660 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 661 663 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
CBP-S436A knockin mice, which exhibit enhanced in vivo and in vitro beta-cell proliferation (9,12), were back-crossed into C57Bl/6 background for six generations. CBP phosphorylation at serine 436 interferes with and reduces CREB/CBP interaction and reduces target gene transcription. Mutation of serine 436 to alanine (forming the mutant CBP-S436A) leads to enhanced basal and cAMP-stimulated transcription of CREB-responsive genes not suppressed by cellular events, which would result in CBP S436 phosphorylation (9,12). Homozygote and heterozygote CBP-S436A mice have similar islet morphometry (Supplemental Table 1, available in an online appendix at ) (11,13) because of the dominant activating CBP-S436A mutation. Therefore, most studies herein were conducted on heterozygous (+/-) knockin mice and wild-type littermates.
###end p 15
###begin title 16
Immunofluorescence histology and islet morphometry.
###end title 16
###begin p 17
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
Pancreata were fixed and stained, and islet morphometry was performed as previously described (9) and as summarized in the supplemental methods available in the online appendix.
###end p 17
###begin title 18
Islet studies.
###end title 18
###begin p 19
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1157 1158 1148 1149 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1583 1585 1573 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
Islets were isolated as previously described (9) and initially incubated in 24-well culture plates in RPMI-1640, 5 mmol/l glucose supplemented with 10% FCS, and 1% penicillin/streptomycin for 24 h before performing additional procedures. For beta-cell apoptosis induction, islets were exposed to 1.5 mmol/l STZ for an additional 24 h before harvest (positive control of apoptosis). Islet exposure to 20 nmol/l exendin-4 was for 8 h after the initial time course studies, when islets were exposed for 0, 2, 4, 6, 8, and 12 h to PBS or exendin-4. cDNA synthesis from islet RNA and quantitative RT-PCR were performed using iScript One-tube RT-PCR with SYBR green on an iCycler (BioRad). Transcript levels were normalized to expression of housekeeping gene 36B4 in corresponding samples. PCR protocols and primers used for quantitative RT-PCR can be obtained on request. For lentiviral infection, freshly isolated islets were incubated in a microcentrifuge tube containing concentrated lentivirus (see supplemental methods), centrifuged at 2,000 rpm for 2 min, transferred to the a 96-well microtiter plate, and incubated at 37degreesC in 95% humidity and 5% CO2. Western immunoblots were performed with 20-40 mug islets protein in radioimmunoprecipitation assay buffer using standard protocols. Information on antibodies used for immunoblots will be provided on request. Immunoblots for cyclin D subtypes were also performed using monoclonal antibodies (Neomarkers) that are specific for cyclin D1-D3 subtypes. Cyclin A1 was not examined because of its restricted expression to gonads (14). Parallel protein detection for actin was used to control for protein loading. Band intensity of interrogated protein was normalized to the corresponding actin intensity (BioRad Chemidoc XRS). Representative immunoblots are shown. Immunoblots were repeated at least four times.
###end p 19
###begin title 20
Cells and transfections.
###end title 20
###begin p 21
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
Min6 cells (passages 25-34) were cultured as described previously (13). Plasmids used are summarized in the supplemental methods.
###end p 21
###begin title 22
Chromatin-immunoprecipitation assay.
###end title 22
###begin p 23
###xml 222 228 <span type="species:ncbi:10090">murine</span>
###xml 407 413 <span type="species:ncbi:9986">rabbit</span>
###xml 480 486 <span type="species:ncbi:9986">rabbit</span>
Chromatin-immunoprecipitation (ChIP) assay was performed according to manufacturer's instructions (ChIP assay kit; Upstate) to detect binding of CREB and recruitment of CBP to the CRE containing regulatory elements in the murine insulin (positive control) and cyclin A2, D1, and D2 genes. ChIP was performed on DNA extracted from cultured MIN6 treated with or without exendin-4 as described above. Specific rabbit anti-CREB antibody (D. Ginty, Johns Hopkins University) or normal rabbit IgG antibody (Santa Cruz sc-2027) were used for immunoprecipitation. PCR was performed for 30 cycles of 30 s each of 94degreesC melting, 58degreesC annealing, and 72degreesC extension steps. An aliquot of the PCR product was fractionated on a 2% agarose gel containing ethidium bromide for UV visualization.
###end p 23
###begin title 24
Small interfering RNA knockdown studies.
###end title 24
###begin p 25
###xml 46 52 <span type="species:ncbi:10090">murine</span>
###xml 79 85 <span type="species:ncbi:10090">murine</span>
Small interfering RNA (siRNA) (100 nmol/l for murine cyclin A2, 200 nmol/l for murine PDX-1, or corresponding amounts for scrambled siRNA; Ambion) were transfected using Fugene (Roche; 1 or 2.5 mul per well in a 24- or 6-well plate, respectively) according to the manufacturer's instructions. For siRNA-mediated knockdown in cultured primary islets, respective siRNA (400 nmol/l with Fugene 10 mul per well in 24-well culture plate) was added to the culture medium. Culture medium and siRNA were replaced every 12 h four times before islet harvest and further analysis. Primers for cyclin A2 (sense, 5'-GCUCAAGACUCGACGGGUtt-3') and PDX-1 (sense, 5'-GGGAACUUAACCUAGGCGUtt-3') effectively reduced cyclin A2 or PDX-1 (see below) levels as determined by immunoblot and were used in all subsequent studies, respectively.
###end p 25
###begin title 26
cAMP measurements.
###end title 26
###begin p 27
cAMP measurements were performed on cultured Min6 and cultured islet extracts. Studies were performed in sextuplicate (Min6) or quadruplicate (cultured islets), and cAMP was measured by ELISA according to manufacturer's instructions (Assay Design).
###end p 27
###begin title 28
Statistical analysis.
###end title 28
###begin p 29
###xml 169 170 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 237 238 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Results are shown as averages and means +/- SE. Calculations were conducted using either Prism 4 (Graph Pad) or Excel (Microsoft) software. Where appropriate, Student's t test or ANOVA was used to calculate differences between groups. A P value of <0.05 was considered significant and is indicated with an asterisk.
###end p 29
###begin title 30
RESULTS
###end title 30
###begin title 31
Exendin-4 treatment increases islet cyclin A2 and Skp2 protein levels.
###end title 31
###begin p 32
###xml 147 148 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 208 209 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 210 211 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 333 335 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
Of the islet cell population, 75-90% are beta-cells. Furthermore, GLP-1 receptor is expressed primarily on beta-cells within the pancreatic islet (4), and all beta-cells participate equally in proliferation (2,3). Thus, changes in whole-islet protein extracts reflect mainly, if not exclusively, changes in beta-cell protein levels (15).
###end p 32
###begin p 33
###xml 120 122 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 236 237 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 230 237 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 238 239 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 464 465 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 488 490 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 531 532 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 583 584 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 615 616 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 609 616 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 621 628 597 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 715 717 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Islet size increased by approximately1.7-fold in exendin-4-treated C57Bl/6 mice, consistent with previous observations (16). This increase is due to beta-cell hyperplasia and not hypertrophy because beta-cell size did not change (Fig. 1A-F). Surprisingly, the D-type cyclin levels, which are considered to respond to extracellular growth stimuli, were not changed in exendin-4-treated islets. Exendin-4 treatment was associated with elevated PDX-1 (1.93 +/- 0.20, P < 0.05) (as expected; 16), cyclin A2 (2.69 +/- 0.17 vs. control, P < 0.05) and Skp2 (5.01 +/- 0.98-fold vs. control, P < 0.05) protein levels (Fig. 2A and Table 1). Islet levels of p27 in the relatively young animals (8-12 weeks) were, as expected (17) low and decreased during exendin-4 treatment.
###end p 33
###begin title 34
Nuclear cAMP-CREB upregulation stimulates cyclin A2.
###end title 34
###begin p 35
###xml 235 236 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 248 251 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 457 458 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 451 458 439 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>G</italic></xref>
###xml 459 460 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 463 464 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 566 569 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 656 657 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 880 881 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 874 881 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 883 890 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 252 256 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
Because exendin-4 stimulates both the PI 3-kinase and cAMP pathways, we assessed specifically the in vivo effects of upregulated nuclear cAMP-CREB-CBP signaling (CBP-S436A knockin mouse) and increased beta-cell mass and proliferation (9). CBP-S436A+/- mice exhibited increased beta-cell Ki67 staining compared with wild-type littermates. This was paralleled by increased beta-cell area without change in beta-cell size (hyperplasia, not hypertrophy) (Fig. 1G-L) (9). In isolated islets, D-type cyclin protein levels were not different between wild-type and CBP-S436A+/- mice. In contrast, cyclin A2 levels were elevated by approximately2.02 +/- 0.20-fold (P < 0.05) in CBP-S436A mutants. p27 was low but detectable in control islets and below detectable levels in CBP-S436A islets. Skp2, FoxO1, and Pdx-1 levels were similar in wild-type and in CBP-S436A littermate islets (Fig. 2B; Table 1). Taken together, the findings in CBP-S436A mice suggest that beta-cell activation of the cAMP-PKA-CREB-CBP pathway leads to cyclin A2 expression without changes in PDX-1, FoxO1, and Skp2.
###end p 35
###begin title 36
Exendin-4 stimulates cyclin A2 and PDX-1 transcript in cultured islets.
###end title 36
###begin p 37
###xml 187 188 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 189 191 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 530 536 527 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
###xml 538 545 535 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
We next focused on the effects of exendin-4 on transcript and protein levels of cyclin A2, cyclin D2 (which among the D-type cyclins is considered most prominent in beta-cell simulation [3,10]), and PDX-1. In cultured islets, exendin-4 stimulation was associated with a rapid (within 2 h) approximate twofold upregulation of cyclin A2 transcript (quantitative RT-PCR) and protein levels. In contrast, PDX-1 transcription and protein levels increased after 4-6 h of exendin-4 stimulation, whereas cyclin D2 levels remained stable (Fig. 3; Table 2). These results indicate that cyclin A2 transcription responds more rapidly than PDX-1 transcription to exendin-4 stimulus.
###end p 37
###begin title 38
Exendin-4 stimulates cyclin A2 via cAMP-PKA-CREB and Skp2 via PI 3-kinase in Min6 cells.
###end title 38
###begin p 39
###xml 144 145 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 250 256 242 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 527 528 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 827 828 813 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1019 1020 1003 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1143 1144 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1176 1182 1158 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
In transient transfections, 20 nmol/l exendin-4 (for 4 h) stimulated -800-bp cyclin A2-LUC reporter activity by 3.7- +/- 0.7-fold (mean +/- SE, P < 0.05), whereas the CRE mutant of the reporter (-800-bp DeltaCRE cyclin A2-LUC) showed no stimulation (Fig. 4). The exendin-4 effect was blocked by the cAMP antagonists H89 and PKI but not by inhibition of the PI 3-kinase and MEK pathways. Constitutively active catalytic subunit of PKA (PKAcs) significantly stimulated -800-bp cyclin A2-LUC reporter activity (4.7- +/- 0.4-fold, P < 0.05) but not that of the corresponding CRE-mutated reporter. Endogenous cyclin A2 protein levels are stimulated by exendin-4 treatment (see below). CREB overexpression stimulated -800-bp cyclin A2-LUC 9.2- +/- 1.1-fold, whereas dominant-negative A-CREB reduced reporter activity to 0.4 +/- 0.1 (P < 0.05). CREB-CBP (CREB-DIEDML) stimulated cyclin A2-LUC transcription (data not shown). Transfection of CREB and CBP together significantly enhanced reporter activity by 7.5- +/- 1.9-fold (P < 0.05 vs. control). Replacement of CBP by the CBP-S436A mutant increased transcriptional activity by 25.7- +/- 6.6-fold (P < 0.05 vs. control and CBPwt) (Fig. 4).
###end p 39
###begin p 40
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Based on observations made in CBP-S436A mice, islet Skp2 levels are not stimulated by the cAMP-CREB-CBP pathway. Exendin-4-stimulated Skp2 elevation was prevented by pharmacologic PI 3-kinase (Supplemental Fig. 1) but not by cAMP signaling inhibition, respectively. In summary, in Min6 cells, exendin-4 stimulates cyclin A2 transcription and protein levels by way of cAMP-PKA-CREB-CBP signaling. Skp2 is elevated via the PI 3-kinase pathway, consistent with previous observations (18).
###end p 40
###begin title 41
CREB binds to cyclin A2 but not to D1 or D2 promoter CRE.
###end title 41
###begin p 42
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 229 234 <span type="species:ncbi:10090">mouse</span>
Using ChIP, we examined whether CREB occupies endogenous promoter elements of cyclin A2 and cyclins D1 and D2, which have been reported to contain CRE elements. In exendin-4-stimulated Min6 cells, we detected CREB binding to the mouse CRE in insulin 1 and cyclin A2 promoters but not to CRE of cyclin D1 and D2 promoters (Supplemental Fig. 2). We did not detect any CREB binding in the absence of exendin-4 treatment of Min6 cells. This lack of basal binding may reflect the low sensitivity of the ChIP assay or may indicate that exendin-4 stimulation stabilizes a larger hetero-protein complex (19) surrounding CREB on the CRE elements of insulin-1 and cyclin A2 promoters.
###end p 42
###begin title 43
Cyclin A2 knockdown inhibits Min6 proliferation and proliferation stimulation by exendin-4.
###end title 43
###begin p 44
###xml 77 83 65 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 249 250 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 260 266 244 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
###xml 369 375 353 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5</xref>
siRNA transfection achieved approximately40% knockdown of cyclin A2 protein (Fig. 5). This resulted in a significantly reduced Min6 proliferation rate (1.14 +/- 0.02-fold [cyclin A2 siRNA] vs. 1.36 +/- 0.05-fold [scrambled siRNA] expansion in 48 h; P < 0.05) (Fig. 5). Cyclin A2 knockdown completely inhibited exendin-4-induced proliferation stimulation in Min6 cells (Fig. 5).
###end p 44
###begin title 45
Lentiviral-mediated cyclin A2 elevation stimulates Min6 and primary beta-cell proliferation.
###end title 45
###begin p 46
###xml 243 244 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Infection of Min6 cells with lentivirus expressing cyclin A2 (compared with control virus) resulted in elevated cyclin A2 levels and in increased proliferation (fold increase in cell count within 48 h, 3.9 +/- 0.4 vs. 1.5 +/- 0.2 in controls, P < 0.05) of Min6 cells (Supplemental Fig. 3).
###end p 46
###begin p 47
###xml 249 250 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 475 481 454 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f6" ref-type="fig">Fig. 6</xref>
###xml 1291 1293 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1357 1360 1333 1336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
We next tested the effects of cyclin A2 overexpression in freshly isolated C57Bl/6 islets. Lentivirus infection rates were low (approximately5% of insulin-positive beta-cells) but detectable by EGFP expression in cultured islets (Supplemental Fig. 4A). Forty-eight hours after exposure to cyclin A2 expressing lentivirus, infected beta-cells showed significantly increased frequency of Ki67- or pH3B-positive nuclei compared with beta-cells infected with control lentivirus (Fig. 6). Ki67 is positive throughout most of the cell cycle, whereas high phospho-histone 3B levels are restricted to the M phase of the cell cycle. Accordingly, and as expected, Ki67 antigen was detected more frequently than pH3B in cyclin A2-expressing lentivirus-infected cells. Lentivirus overexpression of cyclin A2 in isolated islets resulted in reduced p27 and unchanged Skp2 protein levels (Supplemental Fig. 7; Supplemental Table 4), consistent with findings made in CBP-S436A islets. Taken together, these results indicate that cyclin A2 overexpression results in increased proliferation activity in primary pancreatic beta-cells. In contrast to STZ-treated islets, islets infected with cyclin A2 lentivirus for 48 h did not exhibit any detectable apoptosis marker cleaved caspase 3 or in the TUNEL assay (20). In addition, animals treated with exendin-4 and the CBP-S436A+/- animals did not exhibit cleaved caspase 3 (Supplemental Fig. 4). These data indicate that apoptosis is not increased in beta-cells with cyclin A2 overexpression.
###end p 47
###begin title 48
Homeodomain transcription factor PDX-1 is required for cAMP generation and exendin-4 stimulation of cyclin A2.
###end title 48
###begin p 49
###xml 81 82 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 83 84 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 85 87 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
PDX-1 is required for exendin-4 effects on beta-cell proliferation and function (6,8,21). Therefore, we examined the role of PDX-1 in exendin-4-stimulated cyclin A2 expression. siRNA-mediated PDX-1 knockdown for 48 h in Min6 cells had no effect on baseline cyclin A2 levels (1.02 +/- 0.6 compared with no siRNA, NS) but prevented significant increase of cyclin A2 by exendin-4 stimulation (from 1.02 +/- 0.6 to 1.21 +/- 0.1 compared with control). Furthermore, PDX-1 knockdown prevented exendin-4-stimulated -800-bp cyclin A2-LUC activity. Exendin-4-stimulated cAMP generation was diminished by PDX-1 knockdown. The effect of PDX-1 knockdown on cAMP generation was seen after 48 h and not after 24 h of PDX-1 knockdown (data not shown), suggesting an indirect effect of PDX-1 reduction on cAMP generation and cyclin A2 transcription. PKAcs, which acts downstream of cAMP, rescued -800-bp cyclin A2-LUC activity in Min6 when siRNA-mediated PDX-1 levels and cAMP generation are reduced (Supplemental Fig. 5; Supplemental Table 2).
###end p 49
###begin p 50
In primary cultured islets, cyclin A2 knockdown did not influence exendin-4 stimulation of PDX-1 or of cAMP generation. In contrast, PDX-1 knockdown prevented exendin-4 effects on cyclin A2 stimulation, which was also accompanied by reduced exendin-4-induced cAMP generation (Supplemental Fig. 6; Supplemental Table 3).
###end p 50
###begin p 51
###xml 192 194 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
On exendin-4 binding to the GLP-1 receptor (GLP-1R), a trimer of G-coupled proteins associates to the GLP-1R, of which Gsalpha is instrumental in generating cAMP via adenylcyclase activation (22). We therefore examined the effects of siRNA-mediated PDX-1 knockdown on GLP-1R and Gsalpha expression. PDX-1 knockdown reduced both GLP-1R and Gsalpha transcripts (Supplemental Fig. 8; Supplemental Table 5).
###end p 51
###begin title 52
DISCUSSION
###end title 52
###begin p 53
###xml 553 555 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
The studies herein indicate that in addition to proliferation stimulation via PI 3-kinase-mediated signaling, exendin-4 stimulates cyclin A2 expression in pancreatic beta-cells by way of cAMP-PKA-CREB signaling. The effect of exendin-4 on cyclin A2 transcription stimulation depends on the PI 3-kinase-PKB/Akt-FoxO1-PDX-1 pathway, with PDX-1 being necessary for adequate exendin-4-stimulated cAMP generation. Furthermore, in Min6 cells, exendin-4 treatment, via PI 3-kinase-mediated signaling, stimulates Skp2 protein, consistent with previous studies (18). In addition, our studies suggest that upregulation of cyclin A2 levels are sufficient to stimulate beta-cell proliferation.
###end p 53
###begin p 54
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 97 98 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 109 112 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 580 586 568 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 675 682 663 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Figs. 2</xref>
###xml 687 688 675 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">3</xref>
###xml 749 750 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 874 877 856 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1007 1008 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1237 1238 1213 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 1239 1241 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 1490 1492 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 1528 1530 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 1847 1849 1814 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1930 1932 1897 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 878 882 <span type="species:ncbi:10090">mice</span>
The two in vivo mouse models presented herein, 1) exendin-4 stimulated pancreatic beta-cells and 2) CBP-S436A+/- knockin mouse models, provide complementary information on cAMP-dependent and -independent cell cycle regulation. The former studies provide a model of incretin trophic effects on beta-cells, whereas the latter provide a means to dissect the cAMP-CREB-CBP pathway from other incretin-induced intracellular signaling pathways in the regulation of beta-cell proliferation. Our in vivo studies indicate that exendin-4-induced increased beta-cell proliferation and mass (Fig. 1) are accompanied by changes in cell cycle regulatory proteins cyclin A2, Skp2, and p27 (Figs. 2 and 3). CBP-S436A mutant mice exhibit hepatic insulin resistance (9), which as stimulus may contribute to the increased beta-cell mass. However, as previously shown, beta-cells from CBP-S436A+/- mice continue to proliferate ex vivo in cultured islets, indicating that the proliferation has a beta-cell autonomous component (9). Our studies in Min6 cells indicate that exendin-4-stimulated cyclin A2 is mediated via cAMP signaling, whereas Skp2, which has been recently been shown to be critical in regulating beta-cell proliferation via p27 degradation (3,10), is stimulated independently of cAMP signaling via a PI 3-kinase-mediated pathway. Ex vivo beta-cell overexpression of cyclin A2 is associated with stimulated proliferation activity, as assessed by Ki67 (G1, S, M, and G2 phases of the cell cycle [23]) and phospho-histone-3B (M phase [24]) expression without evidence for beta-cell apoptosis. Thus, overexpression of cyclin A2 is sufficient to promote beta-cell proliferation. These findings are consistent with the observation that cyclin A2 is unique among the cyclins in that it regulates progression at both the G1/S and G2/M checkpoints of mitosis (25) and cyclin A2 overexpression alone in cardiomyocytes stimulates proliferation (26).
###end p 54
###begin p 55
###xml 118 124 118 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 126 133 126 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 922 923 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 924 926 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
A possible additional explanation for increased cyclin A2 levels in exendin-4-treated mouse islets is increased Skp2 (Fig. 2; Table 1), which is reported to bind to and stabilize cyclin A2 levels (27,28). However, CBP-S436A+/- animals exhibit beta-cell proliferation activity and elevated cyclin A2 without changes in Skp2. In addition, our transient transfection studies in Min6 cells indicate that intracellular cAMP-PKA signaling directly regulates cyclin A2 transcription. On the basis of these observations, we favor direct cAMP-CREB-CBP-responsive activation of the cyclin A2 transcription as the main mechanism underlying elevated cyclin A2 levels during exendin-4 treatment. It is important to note that CBP-S436A mutant transcriptional upregulation is specific for CREB-CBP interaction and does not influence transcription activity of other transcription factors such as FoxO1 or hypoxia-inducible factor 1alpha (9,12).
###end p 55
###begin p 56
###xml 25 31 25 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 188 194 188 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 301 303 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 483 485 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 668 670 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 809 815 803 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2</xref>
###xml 961 963 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1253 1255 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 1537 1540 1525 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1811 1813 1796 1798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 1541 1545 <span type="species:ncbi:10090">mice</span>
The islet p27 reduction (Fig. 2), which is required for cell cycle entry, is common to both mouse models reported here (29). p27 levels are low in the islets of our relatively young mice (Fig. 2), consistent with observations that beta-cell p27 increases with age, which prevents beta-cell expansion (17). Reduction of p27 levels may occur by multiple pathways, which lead to p27 phosphorylation and phosphorylation-dependent ubiquitination and degradation mediated by Skp2 (rev. in 30). The treatment of C57Bl/6 mice with exendin-4 and studies in Min6 cells indicate that Skp2 elevation likely contributes toward p27 reduction, consistent with previous observations (11). However, in CBP-S436A islets and cyclin A2 overexpression in islets, changes in Skp2 protein levels are not required for p27 reduction (Fig. 2; Supplemental Fig. 7). Formation of cyclin A2-cyclin-dependent kinase (cdk) 1 or A2-cdk 2 complexes lead to p27 phosphorylation and degradation (31), which likely is achieved with the existing Skp2 levels in CBP-S436A beta-cells and cyclin A2 overexpression in isolated islets. In summary, p27 levels are most likely reduced by multiple pathways, and as recently reported, in beta-cells Skp2 is required for p27 proteosomal degradation (11). The CBP-mutant studies indicate that p27 reduction can be achieved directly or indirectly by nuclear cAMP-CREB-CBP-responsive transcription. Importantly, exendin-4-treated animals required 5 days to achieve an increase in islet size similar to that found in 12-week-old CBP-S436A+/- mice. This time difference may be due in part to elevated Skp2 in exendin-4-treated animals, and as downstream effects, more rapid beta-cell proliferation compared with CBP-S436A islets. Although our studies are consistent with PI 3-kinase-mediated stimulation of Skp2 (18), the exact mechanisms underlying incretin-mediated changes in Skp2 levels in beta-cells remain to be elucidated.
###end p 56
###begin p 57
###xml 93 94 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 213 215 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 366 367 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 368 370 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 409 410 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 411 413 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 678 679 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 965 966 953 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 1037 1038 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 1122 1123 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 1497 1498 1478 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1499 1501 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 1658 1661 1639 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1779 1786 1757 1764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Figs. 1</xref>
###xml 1787 1788 1765 1766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">3</xref>
###xml 1662 1666 <span type="species:ncbi:10090">mice</span>
beta-Cell-specific ablation of PDX-1 markedly reduces GLP-1-induced beta-cell proliferation (8), whereas other salient beta-cell properties, such as glucokinase activity, mitochondrial metabolism, ATP generation (21), and levels of mRNA transcripts of important proteins such as IRS2, CREB, and transcription factors Nkx2.2 and Isl1, remain intact at normal levels (8,21). Consistent with these observations (5,21), the present findings confirm that PDX-1 expression is required for cAMP generation in pancreatic beta-cells. The association between PDX-1 and exendin-4-stimulated cAMP formation and downstream cyclin A2 transcription is supported by the following observations: 1) PDX-1 knockdown decreases cAMP generation and cyclin A2 activation by exendin-4. The effect of PDX-1 knockdown on cAMP generation was seen after 48 h of PDX-1 knockdown and not after 24 h (data not shown), which may reflect PDX-1 protein half-life and/or an indirect effect of PDX-1. 2) PDX-1 knockdown reduces GLP-1R and Gsalpha transcript in beta-cells. 3) PDX-1 knockdown effects can be rescued by the cAMP downstream effector PKAcs. And 4) PKA inhibition with H89 or PKI supresses exendin-4 stimulation of cyclin A2 transcription when PDX-1 is not knocked down. In cultured isolated islets, which have high PDX-1 levels, transcription of cyclin A2 responds to exendin-4 more rapidly than PDX-1 transcription. These results are consistent with indirect (via IRS2 and FoxO1) exendin-4-stimulated PDX-1 expression (5,32), whereas direct exendin-4-cAMP-mediated cyclin A2 stimulation occurs more rapidly. Although PDX-1 is required for cAMP generation, the studies in CBP-S436A+/- mice argue that augmentation of PDX-1 levels above baseline is not essential for initiating beta-cell proliferation (Figs. 1-3).
###end p 57
###begin p 58
###xml 176 177 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 178 180 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 359 361 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 577 579 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
PDX-1 knockdown is associated with reduced GLP-1R and Gsalpha transcript in primary islets (Supplemental Fig. 8), consistent with reports of PDX-1-dependent GLP-1R expression (8,21). Our studies extend these observations in that PDX-1 is required for Gsalpha expression. Studies in cell lines indicate that PDX-1 does not directly regulate GLP-1R or Gsalpha (33). We therefore speculate that PDX-1 knockdown indirectly reduces GLP-1R and Gsalpha. Furthermore, the findings herein are consistent with reduced beta-cell proliferation in beta-cell-specific Gsalpha knockout mice (22).
###end p 58
###begin p 59
###xml 193 194 184 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 195 197 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 383 385 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 386 388 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 809 811 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 923 925 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 926 928 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 131 135 <span type="species:ncbi:10090">Mice</span>
###xml 200 204 <span type="species:ncbi:10090">Mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
In pancreatic beta-cells, cyclins D1 and D2 and their interacting partner cdk 4 are essential for postnatal beta-cell replication. Mice lacking cyclin D1 and D2 exhibit reduced beta-cell mass (3,10). Mice lacking cdk 4 in beta-cells exhibit reduced islet mass and diabetes, and mice overexpressing constitutively active cdk 4 in beta-cells exhibit increased beta-cell proliferation (34,35). The present studies do not exclude a role for D-type cyclins, for cdk 4 (and 6), or for nonexendin-4 extracellular growth stimuli in beta-cell proliferation. Our findings suggest a differentiated response of beta-cells to extracellular growth factors with cyclin A2 being responsive to the cAMP-PKA-CREB-CBP pathway, whereas the D-type cyclins possibly respond to growth factor stimuli other than cAMP or PI 3-kinase (36). Previous reports have suggested that cyclins D1 and D2 respond to the cAMP pathway in in vitro cell systems (37-39). We do not find any evidence for exendin-4 or CREB-CBP-mediated elevation in D-type cyclins. Thus, on the basis of our results, we conclude that in adult beta-cells, exendin-4 likely does not participate in regulating D-type cyclin protein levels.
###end p 59
###begin p 60
In summary, the current studies indicate that exendin-4 stimulates cyclin A2 transcription and protein levels via the cAMP-PKA-CREB-CBP pathway. Exendin-4 stimulates Skp2 levels via the PI 3-kinase pathway. Decreased p27 protein levels accompany these changes. Overexpression of cyclin A2 by lentivirus infection in primary pancreatic beta-cells is sufficient to stimulate beta-cell proliferation activity. Furthermore, our studies provide additional evidence for the central role of homeodomain transcription factor PDX-1 in beta-cell proliferation, with PDX-1 being required for cAMP generation.
###end p 60
###begin title 61
Supplementary Material
###end title 61
###begin title 62
Online-Only Appendix
###end title 62
###begin p 63
B.D.K. has received an Endocrine Society Student Research Fellowship. F.E.W. has received National Institutes of Health (NIH) Grant R01-63349. M.A.H. has received NIH Grant R01-64646 and Juvenile Diabetes Research Foundation grants 1-2006-80 and 1-2003-162.
###end p 63
###begin title 64
REFERENCES
###end title 64
###begin p 65
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 248 249 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 265 266 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 297 298 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 313 316 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 318 319 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 334 335 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 337 338 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 340 341 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 347 348 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 377 385 374 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top left</italic>
###xml 414 423 411 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top right</italic>
###xml 492 503 489 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom left</italic>
###xml 542 554 539 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom right</italic>
###xml 626 627 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 657 658 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 690 691 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 770 771 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 800 801 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 844 845 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 893 894 878 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 906 909 891 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 916 917 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 949 950 934 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 1029 1030 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 1059 1060 1035 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 1103 1104 1076 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 1233 1234 1204 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
Exendin-4 treatment and CBP-S436A+/- mutation result in increased beta-cell proliferation and islet size. Representative fluorescence photomicrographs with pseudo-coloring of islet sections of C57Bl/6 littermates treated with either vehicle (PBS) (A) or exendin-4 (B) for 5 days and of wild-type (G) and CBP-S436A+/- (H) littermates. A, B, G, and H are partitioned as follows: top left, DAPI nuclear stain (blue); top right, fluorescein isothiocyanate (FITC) immunostain for insulin (green); bottom left, Cy3 immuno-stain for Ki67 (red); and bottom right, a merged image of the three preceding panels. Compared with controls (A), exendin-4-treated animals (B) exhibit increased islet area (C), beta-cell proliferation as assessed by Ki67 in insulin-positive beta-cells (D), and beta-cells per islet (E) and unchanged calculated beta-cell size (F). Similarly, compared with wild-type controls (G), CBP-S436A+/- mice (H) exhibit increased islet area (I), beta-cell proliferation as assessed by Ki67 in insulin-positive beta-cells (J), and beta-cells per islet (K) and unchanged calculated beta-cell size (L). Means +/- SE in graphs are provided above the corresponding bars. *Significant difference from the corresponding control with P < 0.05. (Please see  for a high-quality digital representation of this figure.)
###end p 65
###begin p 66
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 235 234 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>A</italic></bold>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 249 250 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 264 265 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>C</italic></bold>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 275 276 275 276 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>D</italic></bold>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>E</italic></bold>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 298 299 298 299 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>F</italic></bold>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 302 303 302 303 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>B</italic></bold>
###xml 314 317 314 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 460 463 460 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 523 524 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic></bold>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 538 539 538 539 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>H</italic></bold>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>I</italic></bold>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 564 565 564 565 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>J</italic></bold>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 573 574 573 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K</italic></bold>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 587 588 587 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>L</italic></bold>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
A: Exendin-4 treatment increases PDX-1, cyclin A2, and Skp-2 and decreases p27 islet protein levels. Islets isolated from C57Bl/6 mice treated with either vehicle or exendin-4 for 5 days were analyzed for protein levels of cyclin A2 (A), cyclin D1 (B), cyclin D2 (C), PDX-1 (D), p27 (E), and Skp2 (F). B: CBP-S436A+/- islets exhibit increased cyclin A2 and decreased p27 but unchanged PDX-1 and Skp2 protein levels. Islets isolated from wild-type and CBP-S436A+/- littermates were analyzed for protein levels of cyclin A2 (G), cyclin D1 (H), cyclin D2 (I), PDX-1 (J), p27 (K), and Skp2 (L). Representative immunoblots are shown together with corresponding immunoblot for actin. Corresponding graphs below the immunoblots depict densitometric analysis of antigen band in relation to the corresponding actin band. Data are normalized to the first control densitometry, which is depicted as 1.0 in the first column of the graph. Numbers indicate absolute value of the corresponding column immediately below them.
###end p 66
###begin p 67
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 500 501 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 545 546 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 931 938 929 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 1027 1028 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 617 622 <span type="species:ncbi:10090">mouse</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
A: Exendin-4 stimulates cyclin A2 and PDX-1 transcript in ex vivo-cultured mouse islets. Cultured isolated C57Bl/6 mouse islets were exposed to PBS or 20 nmol/l exendin-4 for 0, 2, 4, 6, 8, and 12 h. Transcript levels of cyclin A2 (A), cyclin D2 (B), and PDX-1 (C) were measured by quantitative RT-PCR. Transcripts were normalized to housekeeping gene 36B4 at corresponding time point and are provided in Table 2 in fold change over baseline (time 0 h) as means +/- SE of quadruplicate experiments. *P < 0.05 and statistical significant change. B: Exendin-4 stimulates cyclin A2 and PDX-1 protein in ex vivo-cultured mouse islets. Cultured isolated C57Bl/6 mouse islets were exposed to PBS or 20 nmol/l exendin-4 for 0, 2, 4, 6, 8, and 12 h. Representative immunoblots for cyclin A2, cyclin D2, and PDX-1 are shown. Densitometric analysis of relative protein levels normalized to actin at corresponding time points are provided in Table 2 and depicted as fold change over baseline (0 h) as means +/- SE of triplicate studies. *P < 0.05 and statistical significant change.
###end p 67
###begin p 68
###xml 383 384 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 428 429 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 516 517 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 561 562 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 803 804 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 809 810 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 949 950 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1114 1115 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1244 1245 1238 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 158 164 <span type="species:ncbi:10090">murine</span>
Exendin-4 stimulates cyclin A2 transcription via the cAMP-PKA-CREB-CBP pathway. Min6 cells transiently transfected with -800-bp 5'-untranslated region of the murine cyclin A2 gene linked to a luciferase cDNA (-800-bp cyclin A2-LUC) or with the same vector carrying a mutation in the CRE (-800-bp DeltaCRE cyclin A2-LUC). Exendin-4 (20 nmol/l for 4 h) stimulates the intact reporter (A) but not the reporter with the mutant CRE (B). Co-transfected expression vector to overexpress active PKAcs stimulates the intact (C) but not the CRE mutant promoter-reporter (D). Short-term (for 20 min before exendin-4 treatment) pharmacological inhibition of cAMP (H89 and PKI), but not other intracellular pathways (U0126 and LY294002) stimulated by exendin-4, inhibits exendin-4 effects on cyclin A2-LUC activity (E and F). Co-transfected expression vector to overexpress CREB stimulates and dominant-negative A-CREB suppresses -800-bp cyclin A2-LUC activity (G). Co-transfected expression vectors to overexpress CREB and CBP-S4356A mutant stimulate cyclin A2-LUC activity more potently than CREB with wild-type CBP (CBPwt) (H). Means +/- SE in graphs are provided above the corresponding bars. *Significant difference from the corresponding control with P < 0.05.
###end p 68
###begin p 69
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1355 1356 1353 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Knockdown of cyclin A2 in Min6 cells reduces proliferation rate. siRNA-mediated knockdown of cyclin A2 in Min6 cells is ascertained by immunoblot for cyclin A2. A representative immunoblot (A, top) with densitometric analysis of cyclin A2 relative to actin levels is shown (A, bottom). Scrambled siRNA does not change cyclin A2 levels (far right column). Data are normalized to the first control densitometry, which is depicted as 1.0 in the first column of the graph. Numbers indicate absolute value of the corresponding column immediately below them. B: Proliferation rate of Min6 cells is reduced by siRNA knockdown of cyclin A2, whereas scrambled siRNA does not influence proliferation rates. Graph depicts cell number at 48 h normalized to start (0 h) after no siRNA (left column), cyclin A2-specific (middle column), or scrambled siRNA (right column), respectively. C: Proliferation rate of Min6 cells is increased by exendin-4 (4 h) treatment and cyclin A2-specific, but not scrambled siRNA, abolishes the exendin-4 stimulation of cell proliferation. Graph depicts cell number at 48 h normalized to start (0 h) after no exendin-4, exendin-4 only, exendin-4 plus cyclin A2-specific siRNA, or scrambled siRNA, respectively. Means +/- SE in graphs are provided above the corresponding bars. *Significant difference from the corresponding control with P < 0.05.
###end p 69
###begin p 70
###xml 87 90 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;D</italic>
###xml 212 213 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 218 219 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 277 278 266 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 283 284 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 332 340 321 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top left</italic>
###xml 340 349 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">subpanels</italic>
###xml 429 447 418 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top right subpanel</italic>
###xml 480 500 469 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle left subpanel</italic>
###xml 522 542 511 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom left subpanel</italic>
###xml 573 574 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 579 580 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 605 606 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 611 612 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 623 644 612 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle right subpanel</italic>
###xml 651 673 640 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom right subpanels</italic>
###xml 994 995 983 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1020 1021 1009 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1296 1297 1245 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1302 1303 1251 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1340 1341 1289 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1346 1347 1295 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1452 1453 1390 1391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1458 1459 1396 1397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1588 1589 1524 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 190 193 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 246 249 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1040 1045 <span type="species:ncbi:10090">mouse</span>
###xml 1085 1088 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1131 1134 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Lentiviral expression of cyclin A2 in mouse islets stimulates beta-cell proliferation. A-D: Representative pseudo-colored digitally imaged sections of islets infected for 48 h with control (CMV-; E1falpha-EGFP) (A and D) or cyclin A2 expressing (CMV-cyclin A2; E1falpha-EGFP) (B and E) lentivirus. Sections (Nomarksi image shown in top leftsubpanels, respectively) are co-immunostained and pseudo-colored for nuclei (DAPI, blue; top right subpanel), virally expressed EGFP (cyan; middle left subpanel), insulin (Cy5, red; bottom left subpanel), proliferation markers Ki67 (A and B) or phospho-histone-3B (D and E) (yellow; middle right subpanel). The bottom right subpanels depict the corresponding merged image of the fluorescence channels within the respective panels. White arrows indicate proliferation marker positive and positive lentivirus infection. Yellow arrows indicate proliferation marker negative, lentivirus postive infection. Quantitaive analysis of proliferation markers Ki67 (C) or phospho-histone 3B (F) in beta-cells of mouse islets infected for 48 h with control (CMV-; E1falpha-EGFP) or cyclin A2-expressing (CMV-cyclin A2; E1falpha-EGFP) lentiviridae. beta-Cells infected with cyclin A2-expressing lentivirus (blacksquare, square, filled) show significantly more Ki67 (Ki67+/EGFP+) and phospho-histone 3B (Phospho-H3B+/EGFP+) expression than beta-cells infected with control virus (square) or beta-cells not infected at all (Ki67+/EGFP-). Means +/- SE in graphs are provided above the corresponding bars. *Significant difference from the corresponding control with P < 0.05. (Please see  for a high-quality digital representation of this figure.)
###end p 70
###begin p 71
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Relative changes of indicated proteins in total islet extracts in exendin-4-treated (5d) C57Bl/6 mice normalized to vehicle-treated controls and CBP-S436A normalized to wild-type littermate islet extracts
###end p 71
###begin p 72
###xml 23 24 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 85 86 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are means +/- SE; n = 4 for each parameter and group. A significant difference (P < 0.05) from the corresponding control is indicated. For details, see text.
###end p 72
###begin p 73
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Exendin-4 stimulates cyclin A2 and PDX-1 in cultured C57Bl6 mouse islets
###end p 73
###begin p 74
###xml 207 208 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
Data are means +/- SE. Relative changes of indicated transcripts and immunoblots of indicated proteins in cultured C57Bl/6 islet extracts treated with PBS or 20 nmol/l exendin-4 for 0, 2, 4, 6, 8, and 12 h (n = 4 for each parameter and group). Transcripts were normalized to housekeeping gene 36B4 transcript at corresponding time points and results are fold change over baseline (0 h). Exendin-4 stimulates an early (2-4 h) increase in cyclin A2, whereas PDX-1 transcript increases after 6-8 h. Densitometric analysis of relative protein levels normalized to actin at corresponding time points of three independent experiments are shown as fold change over baseline (0 h). Exendin-4 stimulates an early (2-4 h) increase in cyclin A2, whereas PDX-1 levels increase after 6-8 h.
###end p 74
###begin p 75
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 92 98 92 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3</xref>
Significant difference (P < 0.05) from the corresponding control. For details, see text and Fig. 3.
###end p 75

